A Phase 1, Randomized, Open Label, Single-Dose Crossover Study to Assess the Relative Bioavailability, Food Effect, and Safety of Capsule Formulations of INF904.
INF904-P1.3
Phase 1 other active
Quick answer
A Phase 1, Randomized, Open Label, Single-Dose Crossover Study to Assess the Relative Bioavailability, Food Effect, and Safety of Capsule Formulations of INF904. for Not applicable, healthy volunteers is a Phase 1 program (other) at InflaRx GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- InflaRx GmbH
- Indication
- Not applicable, healthy volunteers
- Phase
- Phase 1
- Modality
- other
- Status
- active